Vimarsana
Biggest News Aggregation in the World

Page 32 - Colitis Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Colitis Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Colitis Foundation Today - Breaking & Trending Today

Generations of commitment fuel engine of J Edgar and Son - Vimarsana News

Generations of commitment fuel engine of J Edgar and Son

In November 1919, Corporal Joseph Edgar returned to his West Cumbria home of Rowrah, demobbed from the army and ready for civilian life.

Gut fungi amplify inflammation in severe COVID-19 - Vimarsana News

Gut fungi amplify inflammation in severe COVID-19

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

FDA Approves Mirikizumab for Moderately to Severely Active Ulcerative Colitis - Vimarsana News

FDA Approves Mirikizumab for Moderately to Severely Active Ulcerative Colitis

Mirikizumab-mrkz (Omvoh; Eli Lilly and Company) is the first IL-23p19 antagonist approved for adult patients with moderately to severely active ulcerative colitis.

FDA Approves New Drug for Ulcerative Colitis - Vimarsana News

FDA Approves New Drug for Ulcerative Colitis

Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.

Study Compares Upadacitinib and Ustekinumab for Outcomes in Ulcerative Colitis - Vimarsana News

Study Compares Upadacitinib and Ustekinumab for Outcomes in Ulcerative Colitis

Results presented in a paper at ACG 2023 showed upadacitinib was more effective than ustekinumab for achieving clinical response and endoscopic remission.